InvestorsHub Logo
icon url

thefamilyman

09/15/20 12:45 PM

#323662 RE: Lemoncat #323656

Again, you are wrong. The company has already publicized that it is advancing Brilacidin against Covid in a Phase 2 trial. That means humans, not animals. The reason (again) is that animal testing is primarily to determine safety. Efficacy results (positive or negative) for a particular drug in animals often does not translate to humans, so the “fruitless” testing would be if we did an animal trial. Thankfully, Leo is smart enough not to waste our money on “fruitless” animal testing.

Lemoncat said,

It's not necessary but it can save you a lot of money by avoiding a fruitless clinical trial if it fails to work in test animals.

The whole point of this thread was that we have not established any efficacy against COVID in any living creature. So we are not beyond the "mouse and hamster" stage with regard to efficacy.